Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and hydroxychloroquine

pyrazines has been researched along with hydroxychloroquine in 60 studies

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (3.33)24.3611
2020's58 (96.67)2.80

Authors

AuthorsStudies
Amaravadi, RK; Bradner, JE; Chang, YC; Davis, LE; Heitjan, DF; Kaplan, J; Mallon, G; Nichols, CW; Paul, TM; Piao, S; Pontiggia, L; Porter, DL; Rangwala, R; Scott, EC; Stadtmauer, EA; Tan, KS; Vogl, DT1
Amaravadi, RK; Boyiadzis, M; Johnson, DE; Konig, H; Lotze, MT; Sehgal, AR; Tang, D1
Duan, Y; Zhou, C; Zhu, HL1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM1
Şimşek Yavuz, S; Ünal, S1
Costanzo, M; De Giglio, MAR; Roviello, GN1
Hsueh, PR; Jean, SS; Lee, PI1
Alkindi, N; Mazer-Amirshahi, M; Mehta, N; Pourmand, A1
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A1
Chen, K; Couban, RJ; Du, X; Gong, X; Guyatt, G; He, N; Ibrahim, QI; Li, X; Li, Y; Liu, F; Liu, J; Liu, W; Shen, N; Tang, Q; Wu, Z; Xu, X; Ye, Z; Ying, Y; Zhai, S; Zhang, Q; Zhang, Y; Zhou, P1
Campos, L; Gouveia, CC1
Li, C; Ren, L; Wang, L1
Fenioux, C; Funck-Brentano, C; Gligorov, J; Gougis, P; Solas, C; Spano, JP; Veyri, M1
Martinez, MA1
Li, Z; Liu, Y; Wang, D1
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD1
Akova, M; Alp, A; Alp, Ş; Çalık Başaran, N; İnkaya, AÇ; Karahan, S; Metan, G; Öz, ŞG; Özışık, L; Şahin, TK; Sain Güven, G; Taş, Z; Telli Dizman, G; Topeli, A; Ünal, S; Uyaroğlu, OA; Uzun, Ö; Zarakol, P1
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S1
Fujii, H; Hiraoka, N; Horiguchi, M; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T1
Aykaç, K; Cengiz, AB; Ceyhan, M; Cura Yayla, BC; Derin Oygar, P; İlbay, S; Karahan, S; Kukul, MG; Laçinel Gürlevik, S; Özsürekçi, Y1
Aykac, K; Ceyhan, M; Ozsurekci, Y; Yayla, BCC1
Abdelnabi, R; Annaert, P; Augustijns, P; Barthelemy, K; Bervoets, L; Boudewijns, R; Breuer, J; Cawthorne, C; Dallmeier, K; De Keyzer, C; Delang, L; Hens, B; Heylen, E; Jacobs, S; Kaptein, SJF; Langendries, L; Liesenborghs, L; Maas, E; Neyts, J; Pang, J; Rocha-Pereira, J; Rymenants, J; Seldeslachts, L; Solas, C; Spriet, I; Ter Horst, S; Thibaut, HJ; Van Buyten, T; Vande Velde, G; Vergote, V; Verougstraete, N; Weynand, B; Williams, R; Wouters, J; Zhang, X1
Anglaret, X; Binquet, C; Bouchet, S; Crémer, A; Darnaud, T; Dupouy, J; Duvignaud, A; Gimbert, A; Joseph, JP; Journot, V; Lebeaux, D; Lebel, J; Lefèvre, B; Lhomme, E; Malvy, D; Michel, JF; Nguyen, D; Onaisi, R; Orne-Gliemann, J; Peiffer-Smadja, N; Piroth, L; Pistone, T; Poitrenaud, D; Richert, L; Roussillon, C; Sitta, R; Thiébaut, R; Wittkop, L1
Ban, K; Choi, SW; Go, YY; Jung, E; Kim, SJ; Lee, J; Lee, JH; Moon, SH; Park, HJ; Park, SJ; Park, SM; Park, YG; Shin, JS1
Dimopoulos, MA; Fotiou, D; Gavriatopoulou, M; Kastritis, E; Korompoki, E; Migkou, M; Ntanasis-Stathopoulos, I; Psaltopoulou, T; Terpos, E; Tzanninis, IG1
Alaskar, A; Aldibasi, O; Alharbi, A; Aljeraisy, M; AlJohani, S; Almaghaslah, M; Almutairi, B; Alothman, A; Alqahtani, H; Alsaedy, A; Arabi, Y; Bosaeed, M; Bouchama, A; Hussein, M; Mahmoud, E; Nashabat, M1
Vaidyanathan, G1
Asaruddin, MR; Bhawani, SA; Law, WY; Mohamad, S1
Al Bahrani, M; Al Balushi, Z; Al Barwani, U; Al Lawati, A; Al Naabi, H; Al Salmi, I; Al Sharji, M; Al-Zakwani, I; Ambusaidi, Z; Khamis, F; Pandak, N1
Mishra, SK; Tripathi, T1
Govil, A; Luckett, K; Miller-Handley, H1
Kumar, D; Trivedi, N; Verma, A1
da Silva, S; Martinková, I; Petroušová, L; Rožnovský, L1
Wen, S; Xu, X; Yadav, AK; Yu, L1
Keestra, S; Pepperrell, T; Pilkington, V; Rodgers, F1
Dehghan, H; Fazlzadeh, A; Haddad, F; Kheirabadi, D; Mousavi-Roknabadi, RS; Rezaeisadrabadi, M1
Abou-Sleymane, G; Al Faraj, A; Badro, DA; Daou, F; Khanafer, N; Tobaiqy, M1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M1
Danduga, RCSR; James, RA; Kandaswamy, DK; Raj, CTD; Rajasabapathy, R1
Uslu, S1
Akca, HN; Akinci, E; Asfuroglu, E; Ates, I; Aydogan, S; Aypak, A; Bastug, A; Bilgic, Z; Bodur, H; Buzgan, T; Cıvak, M; Erdem, D; Eser, F; Guner, R; Gursoy, FM; Hasanoglu, I; Hezer, H; Izdes, S; Kaya Kalem, A; Kayaaslan, B; Kilic, H; Kucuksahin, O; Tezer Tekce, Y1
Amato, L; Cruciani, F; Davoli, M; De Crescenzo, F; Mitrova, Z; Saulle, R; Vecchi, S1
Alotaibi, NH; Bokharee, N; Khan, YH; Khokhar, A; Mallhi, TH; Rasheed, M1
Dabbous, HM; Ebeid, FFS; El Assal, G; El-Sayed, MH; Elgaafary, M; Elghazaly, H; Fawzy, E; Hassany, SM; Riad, AR; Sherief, AF; TagelDin, MA1
Angkasekwinai, N; Assanasen, S; Chayakulkeeree, M; Chierakul, N; Horthongkham, N; Jitmuang, A; Kantakamalakul, W; Koomanachai, P; Ratanarat, R; Rattanaumpawan, P; Rongrungruang, Y; Sirijatuphat, R; Suputtamongkol, Y; Wangchinda, W1
Avcı, İY; Çetinkaya, RA; Demirtürk, N; Eser, F; Güner, R; Karalezli, A; Kayaaslan, B; Konya, P; Okumuş, N; Orhan, S; Savaşçı, Ü; Şaylan, B; Taşkın, G; Yamanel, L; Yılmaz, G1
Akgun, H; Avci, D; Bilgin, M; Cerci, P; Efe, S; Ozmen, A; Ucan, A; Yagmuroglu, A1
Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D1
Alkan, G; Artac, H; Emiroglu, M; Oz, SKT1
Akbayrak, A; Atak, MF; Farabi, B; Kalelioğlu, MB; Rao, BK1
Altun, D; Ömeroğlu, ŞK; Öztop, B; Temel, F1
Berk, H; Demir Önder, K; Öztoprak, N; Seremet Keskin, A; Seyman, D1
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S1
Abbasov, H; Abishov, E; Aksu, T; Akyay, A; Albayrak, C; Andıç, N; Ar, MC; Ataş, Ü; Aydın Kaynar, L; Balık Aydın, B; Baş, V; Baydar, M; Beköz, HS; Beksaç, M; Bolaman, AZ; Can, F; Çelik, S; Çeneli, Ö; Cengiz Seval, G; Çiftçiler, R; Civriz Bozdağ, S; Demir, AM; Demirci, U; Demircioğlu, S; Diz Küçükkaya, R; Doğan, A; Eroğlu Küçükdiler, H; Erol, V; Göksoy, HS; Güler, N; Gündüz, E; Gürman, G; Gürsoy, V; Güven, ZT; Hindilerden, F; İlhan, O; İnce, İ; Kaynar, L; Keklik, M; Kurt Yüksel, M; Maral, S; Mutlu, YG; Özcan, M; Özkalemkaş, F; Özkocaman, V; Özkurt, ZN; Özsan, GH; Sadri, S; Selim, C; Sevindik, ÖG; Terzi, H; Topçuoğlu, P; Toprak, SK; Ünal, Ş; Üsküdar Teke, H; Yağcı, M; Yavaşoğlu, İ; Yavuz, B; Yavuz, Y; Yegin, ZA; Yılmaz, U; Yönal Hindilerden, İ; Yücel, OK1
Kahraman, ME; Özbuğday, Y; Yüksel, F1
Atli, Z; Aydin, T; Balkan, II; Fresko, I; Hamuryudan, V; Hatemi, G; Melikoglu, M; Ozcifci, G; Ozguler, Y; Oztas, M; Seyahi, E; Tabak, F; Ugurlu, S1
Abdulrahim, Z; Abdulrahman, A; Aljawder, D; Almahroos, A; Alnashaba, F; AlQahtani, M; Alsahaf, F; Alshaikh, F; Atkin, SL; Fayyad, MA; Kumar, N; Mohamed, MW; Otoom, S; Saeed, S1
Aboshabana, R; Belal, F; El Sharkasy, ME; Tolba, MM; Walash, M1
Abdelazim, AH; Hasan, MA; Osman, AO; Ramzy, S1
Berber, N; Cagasar, O; Delen, LA; Derya, S; Gok, A; Gok, Z; Kasapoglu, US; Tetik, B1

Reviews

24 review(s) available for pyrazines and hydroxychloroquine

ArticleYear
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia.
    Leukemia, 2015, Volume: 29, Issue:3

    Topics: Antineoplastic Agents; Autophagy; Boronic Acids; Bortezomib; Cell Survival; Clinical Trials as Topic; Drug Resistance, Neoplasm; Gene Expression; HMGB1 Protein; Humans; Hydroxychloroquine; Leukemia; Leukocytes; Lysosomes; Phagosomes; Pyrazines; Sirolimus

2015
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA, 2020, May-12, Volume: 323, Issue:18

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment

2020
Antiviral treatment of COVID-19
    Turkish journal of medical sciences, 2020, 04-21, Volume: 50, Issue:SI-1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles

2020
Treatment options for COVID-19: The reality and challenges.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin

2020
Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:7

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydroxychloroquine; Interleukin-6; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; SARS-CoV-2

2020
Treatment of SARS-CoV-2: How far have we reached?
    Drug discoveries & therapeutics, 2020, May-06, Volume: 14, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2

2020
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 07-06, Volume: 192, Issue:27

    Topics: Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Hydroxychloroquine; Indoles; Influenza, Human; Lopinavir; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2

2020
Coronavirus Disease 2019: Clinical Review.
    Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment

2020
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Virus research, 2020, Volume: 286

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin

2020
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome

2020
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Journal of infection and public health, 2020, Volume: 13, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2

2020
Potential strategies for combating COVID-19.
    Archives of virology, 2020, Volume: 165, Issue:11

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines

2020
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
    Clinical rheumatology, 2020, Volume: 39, Issue:11

    Topics: Aged; Amides; Antibodies, Antinuclear; Antiviral Agents; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Guanidines; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Pregnenediones; Pyrazines; Recovery of Function; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed

2020
Emerging treatment strategies for COVID-19 infection.
    Clinical and experimental medicine, 2021, Volume: 21, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Humans; Hydroxychloroquine; Immunization, Passive; Palliative Care; Pyrazines; SARS-CoV-2; Treatment Outcome

2021
One year update on the COVID-19 pandemic: Where are we now?
    Acta tropica, 2021, Volume: 214

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses

2021
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
    Advances in chronic kidney disease, 2020, Volume: 27, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Creatinine; Cytidine; Dexamethasone; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Hydroxylamines; Immunization, Passive; Interferons; Janus Kinase Inhibitors; Lopinavir; Pyrazines; Renal Elimination; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ribavirin; Ritonavir; SARS-CoV-2

2020
Possible treatment and strategies for COVID-19: review and assessment.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23

    Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles

2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles

2021
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
    Journal of medical virology, 2021, Volume: 93, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Databases, Factual; Humans; Hydroxychloroquine; Immunoglobulins; Lopinavir; Pandemics; Pyrazines; Respiration, Artificial; Ritonavir; SARS-CoV-2

2021
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
    International journal of environmental research and public health, 2021, 01-22, Volume: 18, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Pyrazines

2021
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
    Archives of microbiology, 2021, Volume: 203, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Repositioning; Evolution, Molecular; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Phylogeny; Prospective Studies; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2

2021
[The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
    Recenti progressi in medicina, 2021, Volume: 112, Issue:3

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Lopinavir; Mesenchymal Stem Cell Transplantation; Pandemics; Pyrazines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Treatment Outcome; Uncertainty

2021
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
    Expert review of anti-infective therapy, 2021, Volume: 19, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Intensive Care Units; Length of Stay; Lopinavir; Methylprednisolone; Observational Studies as Topic; Patient Admission; Pyrazines; Ritonavir; SARS-CoV-2; Survival Rate

2021
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
    Epilepsy research, 2021, Volume: 174

    Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2

2021

Trials

7 trial(s) available for pyrazines and hydroxychloroquine

ArticleYear
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.
    Autophagy, 2014, Volume: 10, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Boronic Acids; Bortezomib; Dose-Response Relationship, Drug; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Recurrence

2014
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to R
    Trials, 2020, Oct-13, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Tolerance; Feasibility Studies; France; Hospitalization; Humans; Hydroxychloroquine; Imatinib Mesylate; Luxembourg; Outpatients; Pandemics; Pneumonia, Viral; Protein Kinase Inhibitors; Pyrazines; Risk Reduction Behavior; SARS-CoV-2; Telmisartan; Therapies, Investigational; Treatment Outcome

2020
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Trials, 2020, Oct-31, Volume: 21, Issue:1

    Topics: Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Inpatients; Male; Multicenter Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; SARS-CoV-2; Saudi Arabia; Time Factors; Treatment Outcome

2020
Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 102

    Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Interferon beta-1b; Male; Middle Aged; Pyrazines; SARS-CoV-2; Treatment Outcome

2021
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
    Scientific reports, 2021, 03-31, Volume: 11, Issue:1

    Topics: Adult; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pyrazines; Treatment Outcome

2021
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    BMC infectious diseases, 2021, May-04, Volume: 21, Issue:1

    Topics: Aged; Amides; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; Pyrazines; Single-Blind Method; Treatment Outcome

2021
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease.
    Scientific reports, 2022, 03-23, Volume: 12, Issue:1

    Topics: Amides; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pilot Projects; Pyrazines; SARS-CoV-2

2022

Other Studies

29 other study(ies) available for pyrazines and hydroxychloroquine

ArticleYear
Advance of promising targets and agents against COVID-19 in China.
    Drug discovery today, 2020, Volume: 25, Issue:5

    Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins

2020
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Current medicinal chemistry, 2020, Volume: 27, Issue:27

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2

2020
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
    European journal of cancer (Oxford, England : 1990), 2020, Volume: 136

    Topics: Amides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Histone Deacetylase Inhibitors; Humans; Hydroxychloroquine; Immunosuppression Therapy; Kidney Diseases; Long QT Syndrome; Lopinavir; Neoplasms; Pandemics; Pneumonia, Viral; Poly(ADP-ribose) Polymerase Inhibitors; Proteasome Inhibitors; Protein Kinase Inhibitors; Pyrazines; Ritonavir; SARS-CoV-2

2020
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
    Journal of nanoscience and nanotechnology, 2020, 12-01, Volume: 20, Issue:12

    Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins

2020
Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
    Turkish journal of medical sciences, 2021, 04-30, Volume: 51, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amides; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Early Medical Intervention; Early Warning Score; Female; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Length of Stay; Male; Middle Aged; Prospective Studies; Pyrazines; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult

2021
Characteristics and Management of Children with COVID-19 in Turkey
    Balkan medical journal, 2020, 10-23, Volume: 37, Issue:6

    Topics: Adolescent; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Length of Stay; Male; Pandemics; Patient Acuity; Pneumonia, Viral; Pyrazines; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Turkey

2020
Characteristics and Management of Children With COVID-19 in a Tertiary Care Hospital in Turkey.
    Clinical pediatrics, 2021, Volume: 60, Issue:3

    Topics: Adolescent; Amides; Antiviral Agents; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Lung; Male; Pediatrics; Pyrazines; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome; Turkey

2021
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 10-27, Volume: 117, Issue:43

    Topics: Amides; Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19 Drug Treatment; Cricetinae; Disease Models, Animal; Disease Transmission, Infectious; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hydroxychloroquine; Lung; Pyrazines; SARS-CoV-2; Treatment Outcome; Vero Cells; Viral Load

2020
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
    Antiviral research, 2020, Volume: 184

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimalarials; Antiviral Agents; Chlorocebus aethiops; Chloroquine; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Flow Cytometry; Heart Diseases; Humans; Hydroxychloroquine; Microscopy, Fluorescence; Myocytes, Cardiac; Pluripotent Stem Cells; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Viral Plaque Assay

2020
Scientists criticize use of unproven COVID drugs in India.
    Nature, 2020, Volume: 587, Issue:7833

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Drugs, Investigational; Humans; Hydroxychloroquine; India; Patient Safety; Placebos; Pyrazines; Reproducibility of Results; SARS-CoV-2; Time Factors; United States; Virus Shedding

2020
Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as M
    BMC research notes, 2020, Nov-11, Volume: 13, Issue:1

    Topics: Amides; Antiviral Agents; Benzaldehydes; Betacoronavirus; Chloroquine; Computer Simulation; Coronavirus 3C Proteases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Hydroxychloroquine; Laurates; Microbial Sensitivity Tests; Models, Molecular; Monoglycerides; Pyrazines; SARS-CoV-2; Structure-Activity Relationship; Tetrodotoxin; Viral Nonstructural Proteins

2020
[Clinical progression of the first wave of novel coronavirus infection in Ostrava].
    Klinicka mikrobiologie a infekcni lekarstvi, 2020, Volume: 26, Issue:3

    Topics: Adenosine Monophosphate; Aged; Alanine; Amides; COVID-19; Czech Republic; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Pyrazines; Respiration, Artificial

2020
Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
    Trials, 2021, Jan-15, Volume: 22, Issue:1

    Topics: Amides; Antiviral Agents; Clinical Trials as Topic; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lopinavir; PubMed; Pyrazines; Registries; Research Design; Research Report; Ritonavir; SARS-CoV-2

2021
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum
    Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines

2021
Myositis due to COVID-19.
    Postgraduate medical journal, 2021, Volume: 97, Issue:1148

    Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creatine Kinase; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Hydroxychloroquine; Lung; Lymphopenia; Magnetic Resonance Imaging; Male; Methylprednisolone; Muscle, Skeletal; Myositis; Pyrazines; SARS-CoV-2; Tomography, X-Ray Computed

2021
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
    Journal of infection and public health, 2021, Volume: 14, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amides; Antiviral Agents; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Intensive Care Units; Male; Middle Aged; Pyrazines; Retrospective Studies; Treatment Outcome; Young Adult

2021
Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital.
    BMC infectious diseases, 2021, Apr-26, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Darunavir; Disease Progression; Drug Combinations; Female; Hospitals; Hospitals, University; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Pyrazines; Referral and Consultation; Retrospective Studies; Ritonavir; Thailand; Treatment Outcome; Young Adult

2021
Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case-control study.
    Virology journal, 2021, 05-25, Volume: 18, Issue:1

    Topics: Aged; Amides; Antiviral Agents; Case-Control Studies; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pyrazines; Retrospective Studies; SARS-CoV-2; Treatment Outcome

2021
Management of COVID-19 pneumonia in a child with NEMO deficiency.
    Immunologic research, 2021, Volume: 69, Issue:4

    Topics: Amides; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Serotherapy; Ectodermal Dysplasia; Genetic Diseases, X-Linked; Humans; Hydroxychloroquine; I-kappa B Kinase; Immunization, Passive; Male; Primary Immunodeficiency Diseases; Pyrazines; SARS-CoV-2

2021
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
    Journal of cosmetic dermatology, 2021, Volume: 20, Issue:8

    Topics: Acute Generalized Exanthematous Pustulosis; Amides; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pyrazines; SARS-CoV-2

2021
Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19
    Turkish journal of medical sciences, 2021, 12-13, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amides; Antimalarials; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Male; Middle Aged; Outpatients; Pyrazines; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Turkey; Young Adult

2021
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients
    Turkish journal of medical sciences, 2021, 12-13, Volume: 51, Issue:6

    Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amides; Antiviral Agents; Clinical Protocols; COVID-19; COVID-19 Nucleic Acid Testing; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pyrazines; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult

2021
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
    Journal of medical virology, 2022, Volume: 94, Issue:1

    Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey

2022
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022, 02-23, Volume: 39, Issue:1

    Topics: Adult; Amides; Azithromycin; Child; COVID-19; Hematologic Neoplasms; Humans; Hydroxychloroquine; Pyrazines; SARS-CoV-2; Turkey

2022
The relationship between Covid-19 and mucociliary clearance.
    Acta oto-laryngologica, 2021, Volume: 141, Issue:11

    Topics: Adrenal Cortex Hormones; Adult; Amides; Antiviral Agents; Case-Control Studies; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Mucociliary Clearance; Nasal Mucosa; Pyrazines; Smoking

2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome.
    Rheumatology international, 2022, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Amides; Antiviral Agents; Behcet Syndrome; Comorbidity; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Incidence; Male; Middle Aged; Prospective Studies; Pyrazines; Treatment Outcome; Young Adult

2022
Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids.
    Luminescence : the journal of biological and chemical luminescence, 2022, Volume: 37, Issue:6

    Topics: Amides; COVID-19 Drug Treatment; Drug Compounding; Humans; Hydroxychloroquine; Pharmaceutical Preparations; Pyrazines; SARS-CoV-2; Spectrometry, Fluorescence; United States; United States Food and Drug Administration

2022
Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022, Nov-15, Volume: 281

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pyrazines; SARS-CoV-2; Spectrometry, Fluorescence

2022
EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA.
    Acta clinica Croatica, 2022, Volume: 61, Issue:3

    Topics: Aged; Amides; Antimalarials; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Progression; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pneumonia; Pyrazines; Retrospective Studies; SARS-CoV-2; Treatment Outcome

2022